OTCMKTS:PHMMF - Pharma Mar Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $1.80 +0.04 (+2.27 %) (As of 07/20/2018 04:00 PM ET)Previous Close$1.76Today's Range$1.80 - $1.8052-Week Range$1.64 - $4.6390Volume3,100 shsAverage Volume2,951 shsMarket Capitalization$399.43 millionP/E RatioN/ADividend YieldN/ABeta-2.81 Company ProfileHeadlinesSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. The company operates through two segments, Biopharmaceuticals and Consumer Chemicals. It develops and commercializes YONDELIS, an antitumor agent for the treatment of advanced soft tissue sarcomas and for relapsed ovarian cancer. The company also has three other clinical-stage programs, including Aplidin, PM1183, and PM184. In addition, it develops and provides diagnostics kit for genetic diagnostics and DNA analysis; and produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain. Receive PHMMF News and Ratings via Email Sign-up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Private households Sub-IndustryN/A SectorMedical SymbolOTCMKTS:PHMMF CUSIPN/A Webwww.pharmamar.com Phone34-91-846-6000 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$200.26 million Price / Sales2.00 Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares222,650,000Market Cap$399.43 Pharma Mar (OTCMKTS:PHMMF) Frequently Asked Questions What is Pharma Mar's stock symbol? Pharma Mar trades on the OTCMKTS under the ticker symbol "PHMMF." What is the consensus analysts' recommendation for Pharma Mar? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pharma Mar in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are some of Pharma Mar's key competitors? Some companies that are related to Pharma Mar include Dunelm Group (DNLMY), Gree,Inc. (GREZF), SUPERDRY PLC/ADR (SEPGY), Clinigen Group (CLIGF), FirstGroup (FGROY), XTEP Intl HOLDI/ADR (XTEPY), Morgan Advanced Ma (MCRUF), Ted Baker (TBAKF), Premier Oil (PMOIY), Hochschild Mining (HCHDF), Cronos Group (CRON), FIH MOBILE Ltd/ADR (FXCNY), COSCO SHIPPING/ADR (CICOY), IQE (IQEPF) and Tcg Bdc (CGBD). Who are Pharma Mar's key executives? Pharma Mar's management team includes the folowing people: Dr. José María Fernández Sousa-Faro Ph.D., Founder, Exec. Chairman, CEO & PresMr. Pedro Fernández Puentes, Exec. Vice-ChairmanMr. Juan Carlos Torres Carretero, Founder (Age 69)Ms. María Luisa de Francia Caballero, Chief Financial OfficerMr. Pascal Besman, Chief Operating Officer Has Pharma Mar been receiving favorable news coverage? News coverage about PHMMF stock has trended somewhat positive on Saturday, Accern reports. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pharma Mar earned a coverage optimism score of 0.15 on Accern's scale. They also assigned press coverage about the company an impact score of 46.04 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days. How do I buy shares of Pharma Mar? Shares of PHMMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Pharma Mar's stock price today? One share of PHMMF stock can currently be purchased for approximately $1.80. How big of a company is Pharma Mar? Pharma Mar has a market capitalization of $399.43 million and generates $200.26 million in revenue each year. How can I contact Pharma Mar? Pharma Mar's mailing address is Avda. De los Reyes 1 Pol. Ind. La Mina, Madrid U3, 28770. The company can be reached via phone at 34-91-846-6000. MarketBeat Community Rating for Pharma Mar (OTCMKTS PHMMF)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 122 (Vote Outperform)Underperform Votes: 129 (Vote Underperform)Total Votes: 251MarketBeat's community ratings are surveys of what our community members think about Pharma Mar and other stocks. Vote "Outperform" if you believe PHMMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PHMMF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/21/2018 by MarketBeat.com StaffFeatured Article: Do closed-end mutual funds pay dividends?